Globus Medical (GMED) Q4 Earnings and Revenues Top Estimates

Core Insights - Globus Medical reported quarterly earnings of $0.84 per share, exceeding the Zacks Consensus Estimate of $0.76 per share, and showing an increase from $0.60 per share a year ago, resulting in an earnings surprise of 10.53% [1] - The company achieved revenues of $657.29 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.02% and up from $616.53 million year-over-year [2] - The stock has underperformed the market with a gain of about 1.7% since the beginning of the year, compared to the S&P 500's gain of 4.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.79 on revenues of $647.24 million, and for the current fiscal year, it is $3.47 on revenues of $2.67 billion [7] - The estimate revisions trend for Globus Medical is mixed, leading to a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Instruments industry, to which Globus Medical belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, OrthoPediatrics, is expected to report a quarterly loss of $0.22 per share, with revenues projected at $52.7 million, reflecting a 40.1% increase year-over-year [9][10]